Recombinant 3rd-generation lentiviral vector displaying the hemagglutinin (HA) of the human influenza H3N2 A/Hong Kong/1/1968 strain. It incorporates a luciferase reporter gene.Performance: 1 µL per well (96-well plate) produces a signal-to-background ratio of 10³ RLU, according to the manufacturer’s protocol. 100 µL = 100 reactions.Validation: Validated lot-to-lot for infection and neutralization.Applications: This pseudovirus can be used to investigate virus entry, receptor recognition, and cellular tropism, to perform functional studies, to screen anti-HA drugs and neutralizing antibodies, or to assess vaccine efficacy. For Research Use Only.Biosafety: Must be handled under BSL-2 conditions. Replication-incompetent and non-pathogenic due to multiple molecular safety modifications.Shipping and storage: Shipped on dry ice and stored at −80 °C. Avoid freeze/thaw cycles. Each shipment includes a complete protocol and a batch-specific quality control report.